NCT06237452
VE303 for Prevention of Recurrent Clostridioides Difficile Infection prevention 3 recruiting NCT06398379
Virus as Treatment of C. Difficile Infection (VISION) No drug interventions treatment Not Available not_yet_recruiting NCT06030245
Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance No drug interventions Not Available Not Available recruiting NCT01957761
Molecular Epidemiology of Clostridium Difficile Infections in Children No drug interventions Not Available Not Available completed NCT06311006
Safety Registry of a Fecal Microbiota Transplant Cohort No drug interventions Not Available Not Available recruiting NCT05714566
Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients No drug interventions Not Available Not Available recruiting NCT06107569
Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma treatment 3 not_yet_recruiting NCT05256693
Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant prevention 3 not_yet_recruiting NCT05430269
Faecal Bacteriotherapy for Postantibiotic Diarrhoea in Critically Ill Patients No drug interventions treatment Not Available recruiting NCT01716533
Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI) No drug interventions basic_science Not Available completed NCT02692651
A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections treatment 4 completed NCT02437591
Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) treatment 4 completed NCT03244644
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) No drug interventions treatment 3 completed NCT04121169
Treatment of Mild-moderate Clostridium Difficile Infection (CDI) No drug interventions treatment 2 recruiting NCT04070352
Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI) Not Available Not Available withdrawn NCT02951702
Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics prevention 4 completed NCT01222702
Efficacy, Safety and Tolerability of Cadazolid in Subjects With Clostridium Difficile Associated Diarrhea (CDAD) treatment 2 completed NCT03005379
Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH) prevention 2 / 3 terminated NCT02996487
Screening to Prophylax Against Clostridium Difficile Infection - prevention 4 completed NCT03643887
Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients No drug interventions prevention 2 withdrawn NCT03795233
Fecal Microbiota Transplant for Primary CDI treatment 1 / 2 terminated NCT05703477
The Dynamic Fluctuation of Donor Microbiota Affects the Prognosis of Fecal Microbiota Transplantation for C. Difficile Infection No drug interventions treatment Not Available completed NCT02570477
FMT for Moderate to Severe CDI: A Randomised Study With Concurrent Stool Microbiota Assessment treatment Not Available active_not_recruiting NCT03827447
Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile treatment 1 completed NCT01077245
Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections No drug interventions treatment 2 withdrawn NCT03053505
A Novel Faecal Microbiota Transplantation System for Treatment of Primary and Recurrent Clostridium Difficile Infection treatment Not Available unknown_status NCT02255305
FMT Versus Antimicrobials for Initial Treatment of Recurrent CDI treatment 2 terminated NCT03183128
ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection No drug interventions treatment 3 completed NCT03182907
Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001) prevention 3 completed NCT02223715
Prospective Observational Study of Clostridium Difficile Infection in Asian Pacific Countries No drug interventions Not Available Not Available completed NCT01704937
Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum treatment 1 completed NCT01972932
Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea No drug interventions prevention 4 terminated NCT01560832
Descriptive Epidemiology of Clostridium Difficile Infection in Hospitalized Adult Patients in the Asia Pacific Region No drug interventions Not Available Not Available completed NCT02301000
IMT for Primary Clostridium Difficile Infection treatment 2 / 3 terminated NCT02237859
Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection prevention 4 unknown_status NCT03462459
Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection prevention 2 completed NCT03141775
Incidence and Economic Burden of Clostridium Difficile Infections (CDI) in the German Health Care System (IBIS) No drug interventions Not Available Not Available unknown_status NCT04138706
Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection prevention 3 active_not_recruiting NCT04960306
Fecal Filtrate as a Treatment Option of Multiple Recurrent Clostridioides Difficile Infection treatment 3 not_yet_recruiting NCT01670149
Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea prevention 4 completed NCT03804736
Fecal Microbiota Transplant by Oral Capsules With Lactobacilli for Recurrent Clostridium Difficile Infection treatment Not Available unknown_status NCT03268213
Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis No drug interventions treatment 0 completed NCT04014413
Safety and Efficacy of Fecal Microbiota Transplantation No drug interventions treatment Not Available recruiting NCT02991417
Oral Vaccination Against Clostridium Difficile Infection No drug interventions prevention 1 terminated NCT02865616
MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI) treatment 1 completed NCT02981316
Treatment of Recurrent Clostridium Difficile Infection With RBX7455 No drug interventions treatment 1 completed NCT02086916
Novel Biomarkers to Predict Outcome in Clostridium Difficile Infection No drug interventions Not Available Not Available unknown_status NCT02092935
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD) treatment 2 completed NCT04317963
Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile Infection Not Available Not Available completed NCT01296386
An Open-label Study Assessing Safety, Immunogenicity and Dose Response of IC84 No drug interventions prevention 1 completed NCT01513239
A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002) treatment 3 completed NCT03712722
Fecal Microbiota Transplantation (FMT) for Clostridium Difficile No drug interventions Not Available Not Available recruiting NCT03030248
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients treatment 2 completed NCT05192148
Seroprevalence of Antibodies to Surface Antigens and Toxins of Clostridioides Difficile No drug interventions other Not Available recruiting NCT03621657
The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation No drug interventions treatment 2 completed NCT02327520
Clostridium Difficile Infection: the First Report in Southeast Asia by 2010 Nationwide Study No drug interventions Not Available Not Available completed NCT01914731
Fecal Microbiota Transplant for Relapsing Clostridium Difficile Infection in Adults and Children Using a Frozen Encapsulated Inoculum treatment 1 completed NCT03848689
FQ Restriction for the Prevention of CDI No drug interventions Not Available Not Available enrolling_by_invitation NCT02461901
Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile? No drug interventions Not Available Not Available completed NCT06367504
A Study to Assess the Effect of Doctor's Biome Medical Food in Individuals With Clostridium Difficile Infection No drug interventions other Not Available not_yet_recruiting NCT03654872
Clostridium Difficile Virulence Mechanism Study (CDVM Study) No drug interventions Not Available Not Available unknown_status NCT04940468
High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology No drug interventions prevention Not Available recruiting NCT03349268
Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection No drug interventions prevention Not Available completed NCT03388268
TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment other 4 completed NCT04305769
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) treatment 2 recruiting NCT04090346
Fecal Microbiota Transplant treatment 4 completed NCT01887912
Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection No drug interventions prevention 3 terminated NCT01987895
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea treatment 3 completed NCT03824795
Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD treatment 2 completed NCT01946750
Predictive Value of the Immune Response of the Host in Clostridium Difficile Infections prevention Not Available completed NCT04014608
Protocol for Admission Toxigenic C. Difficile Surveillance No drug interventions Not Available Not Available completed NCT03834038
Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection treatment Not Available unknown_status NCT02106338
Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123. treatment 1 completed NCT01372943
Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection treatment Not Available terminated NCT04100603
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection No drug interventions Not Available Not Available unknown_status NCT02784002
A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) treatment 2 completed NCT03466502
Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics prevention 4 completed NCT03105479
Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD) treatment 2 / 3 terminated NCT00772954
Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity No drug interventions treatment 1 terminated NCT01822977
The Impact of Proton Pump Inhibitors on the Fecal Microbiome Not Available 1 completed NCT01942447
Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile Colitis treatment Not Available unknown_status NCT02589847
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection No drug interventions treatment 2 completed NCT01842347
Treatment of C. Difficile Infection With Fecal Microbiota Transplantation (FMT) No drug interventions treatment Not Available withdrawn NCT02686645
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection treatment 2 / 3 unknown_status NCT02707198
Prevention of Clostridium Difficile-associated Diarrhea by Daily Intake of Kefir No drug interventions prevention 2 terminated NCT01597505
Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005) treatment 3 completed NCT01983683
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea treatment 3 completed NCT03350711
A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment Program No drug interventions Not Available Not Available suspended NCT01598311
A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006) treatment 3 completed NCT03200093
Oral Vancomycin for Preventing Clostridium Difficile Recurrence prevention 4 terminated NCT02214771
Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients Not Available Not Available completed NCT04012788
CDI Synbiotic Study No drug interventions prevention Not Available unknown_status NCT01905709
Fecal Microbiota Transplantation for C Diff Infection No drug interventions treatment Not Available unknown_status NCT02557685
Gut Microbiota Changes After Fecal Microbiota Transplantation treatment 2 unknown_status NCT01930032
Pathogenic Mechanisms in C Diff Infection and Colitis No drug interventions Not Available Not Available completed NCT01241552
A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001) treatment 3 completed NCT03829475
ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI treatment 2 active_not_recruiting NCT04247542
ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection treatment 2 completed NCT02830542
SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence No drug interventions prevention 1 completed NCT03497806
Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection No drug interventions treatment 2 completed NCT03586206
Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection No drug interventions Not Available Not Available unknown_status NCT02464306
Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection treatment 4 withdrawn NCT03925636
Specific Carbohydrate Diet for Clostridium Difficile No drug interventions treatment Not Available completed NCT02326636
Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection No drug interventions Not Available Not Available completed NCT02399618
Freeze-dried, Capsulized FMT for RCDI treatment 1 unknown_status NCT01295918
Probiotic Lactobacillus Reuteri to Prevent Antibiotic-associated Diarrhea and Clostridium Difficile-related Infections in Hospitalized Children No drug interventions prevention 3 completed NCT03931941
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS) No drug interventions treatment 3 completed NCT01818141
Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin treatment 4 completed NCT03562741
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile No drug interventions treatment Not Available recruiting NCT03788434
Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection prevention 2 completed NCT02743234
Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection treatment 3 completed NCT04567134
Clostridioides Difficile Infection - a Prospective Nationwide Epidemiologic Study in Korea No drug interventions Not Available Not Available unknown_status NCT02968758
Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains No drug interventions diagnostic Not Available completed NCT01958463
Transplantation of Fecal Microbiota for Clostridium Difficile Infection No drug interventions treatment 3 unknown_status NCT00563186
Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial No drug interventions prevention Not Available completed NCT04075422
Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence. Not Available Not Available completed NCT01896830
Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan No drug interventions prevention 1 / 2 completed NCT04187430
Validation of a Prediction Score for Recurrent C. Difficile Infection: Implementation for Treatment Algorithm Strategies No drug interventions Not Available Not Available unknown_status NCT02395848
Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection treatment 3 terminated NCT04698148
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases No drug interventions Not Available Not Available completed NCT01230957
Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults No drug interventions prevention 2 completed NCT01259726
Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection No drug interventions prevention 2 completed NCT03503474
COMBACTE-CDI Understanding the Burden of C. Difficile Infection No drug interventions Not Available Not Available completed NCT03065374
Treatment for Clostridium-difficile Infection With IMM529 No drug interventions treatment 1 / 2 terminated NCT02016820
Effect of Acid Suppression Medication on Pediatric Microbiome basic_science Not Available terminated NCT03592082
Use of Bismuth Subsalicylate in Clostridium Difficile Colitis treatment 4 withdrawn NCT04259931
PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA No drug interventions Not Available Not Available unknown_status NCT03710694
Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI) No drug interventions prevention Not Available completed NCT01085591
Study of CB-183,315 in Participants With Clostridium Difficile Infection treatment 2 completed NCT03090191
Clostridium Difficile Vaccine Efficacy Trial No drug interventions prevention 3 completed NCT04801862
Natural History of Clostridioides Difficile Infection No drug interventions Not Available Not Available recruiting NCT03106844
The ICON Study: Outcomes After FMT for Patients With IBD and CDI treatment 1 / 2 completed NCT05008640
Creation of an E-toileting Log Through Classification of the Physical Properties of Stool and Urine Using TrueLoo™ No drug interventions Not Available Not Available completed NCT03250104
Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives No drug interventions Not Available Not Available completed NCT03025672
Evaluation of the Cost of a Nosocomial Infection With Clostridium Difficile No drug interventions Not Available Not Available completed NCT01552668
Fidaxomicin to Prevent Clostridium Difficile Colonization prevention 4 withdrawn NCT03107169
Treatment of Initial Clostridium Difficile Infection treatment Not Available completed NCT01398969
Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT for Recurrent CDI No drug interventions prevention 2 completed NCT04885946
Fecal Microbiota Transplantation for Early Clostridioides Difficile Infection No drug interventions treatment Not Available active_not_recruiting NCT02053181
Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile Infection Not Available 1 completed NCT04000555
Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI) prevention 4 terminated NCT03325855
Fecal Microbiota Transplant National Registry No drug interventions Not Available Not Available recruiting NCT03796650
Fecal Transplantation for Primary Clostridium Difficile Infection treatment 3 unknown_status NCT02053350
Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection treatment 2 terminated NCT00772343
Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection No drug interventions treatment 2 completed NCT02592343
A Prospective Trial of Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection treatment 2 completed